Publication Name	World Journal of Gastroenterology
Manuscript ID	79728
Country	United States

Received	2022-09-04 04:54
Peer-Review Started	2022-09-04 04:57
To Make the First Decision
Return for Revision	2022-11-05 07:39
Revised	2022-11-20 19:51
Second Decision	2023-01-03 03:42
Accepted by Journal Editor-in-Chief
Accepted by Executive Editor-in-Chief	2023-01-03 06:22
Articles in Press	2023-01-03 06:22
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript	2023-01-04 08:13
Publish the Manuscript Online	2023-01-12 10:19

ISSN	1007-9327 (print) and 2219-2840 (online)
Open Access	This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Copyright	© The Author(s) 2023. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Oncology
Manuscript Type	Review
Article Title	Salvage locoregional therapies for recurrent hepatocellular carcinoma
Manuscript Source	Invited Manuscript
All Author List	Cody R Criss and Mina S Makary
Funding Agency and Grant Number
Corresponding Author	Mina S Makary, MD, Assistant Professor, Attending Doctor, Director, Director, Radiology, The Ohio State University Wexner Medical Center, 395 W. 12th Ave, 4th Floor, Columbus, Ohio 43210, United States. mina.makary@osumc.edu
Key Words	Recurrent hepatocellular carcinoma; Locoregional therapy; Transarterial chemoembolization; Transarterial embolization; Transarterial radioembolization; Ablation; Salvage therapy
Core Tip	Management of recurrent hepatocellular carcinoma (R-HCC) includes surgical resection, systemic treatment, or locoregional therapies including ablation, transarterial chemoembolization, or radioembolization, and stereotactic body radiation therapy. In the setting of recurrence, locoregional therapies offer unique advantages over surgery for select patients. Recent investigations have also highlighted the potential of combining locoregional therapies or adding systemic retreatments for R-HCC.
Publish Date	2023-01-12 10:19
Citation	Criss CR, Makary MS. Salvage locoregional therapies for recurrent hepatocellular carcinoma. World J Gastroenterol 2023; 29(3): 413-424
URL	https://www.wjgnet.com/1007-9327/full/v29/i3/413.htm
DOI	https://dx.doi.org/10.3748/wjg.v29.i3.413

Full Article (PDF)	WJG-29-413.pdf
Full Article (Word)	WJG-29-413.docx
Manuscript File	79728_Auto_Edited-LM.docx
Answering Reviewers	79728-Answering reviewers.pdf
Audio Core Tip	79728-Audio core tip.mp3
Conflict-of-Interest Disclosure Form	79728-Conflict-of-interest statement.pdf
Copyright License Agreement	79728-Copyright license agreement.pdf
Peer-review Report	79728-Peer-review(s).pdf
Scientific Misconduct Check	79728-Bing-Liu GL-2.png
Scientific Editor Work List	79728-Scientific editor work list.pdf
CrossCheck Report	79728-CrossCheck report.pdf